Overview
Tomasz Stoklosa practices in Warsaw, Poland. Mr. Stoklosa is rated as an Experienced expert by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Transplant.
His clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Essential Thrombocythemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Mr. Stoklosa isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Advanced
- LeukemiaMr. Stoklosa isAdvanced. Learn about Leukemia.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Stoklosa isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Blood ClotsMr. Stoklosa isExperienced. Learn about Blood Clots.
- Bone Marrow TransplantMr. Stoklosa isExperienced. Learn about Bone Marrow Transplant.
- Chronic B-Cell Leukemia (CBCL)Mr. Stoklosa isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Stoklosa isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Congenital Fiber-Type DisproportionMr. Stoklosa isExperienced. Learn about Congenital Fiber-Type Disproportion.